Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease

NCT01806610 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic-kidney Disease Stage 5D on Stable Hemodialysis

Interventions

DRUG: BPS804
DRUG: Placebo

Sponsor

Ultragenyx Pharmaceutical Inc

Collaborators

[object Object]
[object Object]